Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile database
Regulatory databases
Regulatory reports
Market reports
Market Snapshots
Infographics
News analysis
Pricing snapshots
Brand price trackers
Flavour trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • United Kingdom ASA upholds complaints against milseading Elf Bar poster…
  • Portugal State Budget 2024 approved, new and increased e-liquid taxes to come…
  • Germany List of notified e-cig products updated…
  • Kuwait E-cigarette tax will not change after all…
  • Finland Tobacco tax bill would not affect e-liquids…
  • France Disposable e-cig bill sees further amendments and discussion…
  • Spain Andalusia to ban nicotine-free e-cig sales to minors…
  • France National Tobacco Control Programme 2023-2027 published…
  • Russia Smugglers of e-liquids could face prison sentence…
  • Russia Tax Code amendment bill signed by president…
  • Germany Product alert bans sales of e-cig containing cannibinoids…
  • Belgium Lists of positive and negative e-cig product notifications updated…
View all
News analysis

Altria keeps fingers crossed on Juul PMTA but ‘will not invest further in vaping’

Written by || 1st February 2022 || News analysis || Companies | FDA | North America United States

US tobacco giant Altria has announced that it will not invest any further in the vapour category for the foreseeable future.

The company said it cannot undertake any organic development in the category because of its agreement with Juul Labs, but it would not look to change its minority investment.

...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents
US FDA rejects 5.5m PMTAs; Juul’s application still under review
FDA technical review throws light on agency’s priorities for e-cigarettes
PMTAs: after the Reynolds approvals, which way will the FDA go next?

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy.